Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Tempest Therapeutics, Inc. (OVAS) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2023 4 Whiting Samuel (Chief Medical Officer) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Granted 69,700 options to buy @ $1.23, valued at $85.7k
01/05/2023 4 Dubensky Thomas W. (President) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Granted 102,700 options to buy @ $1.23, valued at $126.3k
01/05/2023 4 Brady Stephen R (CEO) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Granted 177,300 options to buy @ $1.23, valued at $218.1k
01/05/2023 4 Maestas Nicholas (VP of Strategy and Finance) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Granted 38,425 options to buy @ $1.23, valued at $47.3k
01/05/2023 4 Trojanowski Justin (Corporate Controller) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Granted 20,300 options to buy @ $1.23, valued at $25k
10/04/2022 4 Trojanowski Justin (Corporate Controller) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Granted 2,500 options to buy @ $1.85, valued at $4.6k
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Maestas Nicholas (VP of Strategy and Finance) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Granted 51,270 options to buy @ $2.35, valued at $120.5k
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Dubensky Thomas W. (President) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Granted 87,801 options to buy @ $2.35, valued at $206.3k
06/22/2022 4 Brady Stephen R (CEO) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Granted 173,533 options to buy @ $2.35, valued at $407.8k
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Woiwode Thomas (Director) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Granted 3,500 options to buy @ $2.08, valued at $7.3k
06/22/2022 4 Simantov Ronit (Director) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Granted 3,500 options to buy @ $2.08, valued at $7.3k
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/03/2022 4 Woiwode Thomas (10% Owner) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Bought 2,118,644 shares @ $2.36, valued at $5M
05/03/2022 4 Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 4 on Tempest Therapeutics, Inc.
01/11/2022 4 Dubensky Thomas W. (President) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Bought 2,000 shares @ $4.78, valued at $9.6k
01/10/2022 4 Whiting Samuel (Chief Medical Officer) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Bought 1,700 shares @ $4.8048, valued at $8.2k
01/06/2022 4 Lorenzo Pierre (Corporate Controller) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Granted 6,500 options to buy @ $5.45, valued at $35.4k
01/06/2022 4 Maestas Nicholas (VP of Strategy and Finance) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Granted 19,500 options to buy @ $5.45, valued at $106.3k
01/06/2022 4 Whiting Samuel (Chief Medical Officer) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Granted 29,000 options to buy @ $5.45, valued at $158.1k
01/06/2022 4 Brady Stephen R (CEO) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Granted 94,500 options to buy @ $5.45, valued at $515k
01/06/2022 4 Dubensky Thomas W. (President) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Granted 53,100 options to buy @ $5.45, valued at $289.4k
09/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2021 4 Simantov Ronit (Director) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Granted 6,635 options to buy @ $13.6, valued at $90.2k
07/14/2021 4 Maestas Nicholas (VP of Strategy and Finance) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Granted 23,225 options to buy @ $24.19, valued at $561.8k
07/06/2021 4 Xu Stella (Director) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Granted 6,635 options to buy @ $11.07, valued at $73.4k
07/06/2021 4 Woiwode Thomas (10% Owner) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns: Granted 6,635 options to buy @ $11.07, valued at $73.4k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy